Posted inStock
Exclusive-Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
By Chad Terhune (Reuters) – U.S. government health plans account for the lion’s share of coverage for popular new weight-loss drugs, far beyond the reimbursement available from private employers and…